Cramer Rosenthal McGlynn Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VSXY
Victoria's Secret
VSXY
|
+$25.6M |
| 2 |
Bankunited
BKU
|
+$12M |
| 3 |
Sensient Technologies
SXT
|
+$11M |
| 4 |
ACV Auctions
ACVA
|
+$8.85M |
| 5 |
Capital One
COF
|
+$6.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$32.8M |
| 2 |
Allstate
ALL
|
+$24.1M |
| 3 |
Steven Madden
SHOO
|
+$16.7M |
| 4 |
Arcosa
ACA
|
+$16.5M |
| 5 |
CADE
Cadence Bank
CADE
|
+$14.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.77% |
| 2 | Industrials | 15.99% |
| 3 | Consumer Discretionary | 14.7% |
| 4 | Technology | 13.46% |
| 5 | Real Estate | 8.5% |
Similar funds
Cramer Rosenthal McGlynn's Q1 2025 Portfolio in Review
As of Q1 2025, Cramer Rosenthal McGlynn held 100 positions worth $1.39B, down 22% from $1.77B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Cramer Rosenthal McGlynn withdrew a net $221M in Q1 2025, closing 15 positions and reducing 53 holdings. Its most notable exit was Elanco Animal Health, an estimated $32.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Cramer Rosenthal McGlynn opened a new position in Sensient Technologies worth $11.3M.
- Cramer Rosenthal McGlynn's largest Q1 2025 buy was Sensient Technologies: 151,167 shares worth $11.3M.
- Cramer Rosenthal McGlynn added most to Victoria's Secret in Q1 2025, an estimated $25.6M increase.
- Cramer Rosenthal McGlynn's biggest Q1 2025 reduction was Steven Madden, cutting an estimated $16.7M.
- Cramer Rosenthal McGlynn fully exited Elanco Animal Health in Q1 2025, selling an estimated $32.8M.
- Cramer Rosenthal McGlynn's ten largest holdings make up 27% of its $1.39B portfolio in Q1 2025.
- Cramer Rosenthal McGlynn opened 3 new positions and closed 15 in Q1 2025.
- Cramer Rosenthal McGlynn's portfolio value fell 22% quarter-over-quarter to $1.39B.
Based on Cramer Rosenthal McGlynn's 13F filing for Q1 2025, filed 14 May 2025.